境外治疗期间使用
Use during U.S. treatment
最清晰的路径：美国医生诊疗、美国持牌药房调配、患者在美国使用。
The clearest path: U.S. diagnosis, licensed dispensing, and use while under U.S. care.
CLARITY FOR EVERY STEP OF CARE
复杂的跨境医疗，
也应该有清晰方向。
A clear direction for care
across borders.
当重大疾病让方向变得模糊，我们为患者与家属提供一位稳定、审慎的国际医疗协调顾问，把复杂的信息和行程整理成可以安心走下去的路径。
When serious illness makes the way forward unclear, a trusted international care advisor brings structure, discretion, and calm to every decision.
01资深顾问全程负责Senior advisor led
02谨慎处理家庭隐私Discreet by design
03关键决定从容清晰Clarity at critical moments
中美双向服务U.S. ↔ China coordination
01
复杂病例，清晰路径Complex care, clearly navigated医疗决定始终由接诊地持牌医生作出Clinical decisions remain with licensed treating providers
CARE BEYOND COORDINATION
我们管理的是路径，
We manage the journey.
我们管理的是路径，
但始终看见的是人。
We manage the journey.
We never lose sight of the person.
重大疾病会改变一个家庭的时间感。每一次等待、重复说明和不确定，都可能成为额外负担。我们以清晰但不过度打扰的方式主动沟通，照顾患者的尊严，也照顾家属承受压力的方式。
Serious illness changes a family's sense of time. Every delay and repeated explanation can add weight. We communicate proactively without overwhelming, protecting both patient dignity and family capacity.
可信赖的判断，安静而持续的陪伴。Trusted judgment. Quiet, continuous support.
01
资深顾问负责制Senior advisor ownership一个熟悉全案的人，持续负责每个重要节点One advisor who understands the whole journey
02
严谨机构筛选Considered provider review资质、适配度与患者实际需求同等重要Credentials, fit, and patient needs considered together
03
高度私密沟通Discreet communication克制共享信息，尊重家庭内部的沟通安排Careful information sharing with family consent
04
跨境连续照护Cross-border continuity不止安排一次就诊，也关注之后如何继续治疗Support that extends beyond a single appointment
关于境外药品的重要说明
An important note about medication access
阅读服务边界Read our standards→
“境外有药”不代表可以直接邮寄或带入中国。处方、调配、运输、进口与使用分别受到监管；我们提供就医路径协调，不销售或经手药品。
Availability abroad does not mean a medicine can be shipped or carried into China. Prescribing, dispensing, transport, import, and use are separately regulated. We coordinate care pathways—we do not sell or handle medication.
01
双向服务架构
Two-way service architecture
不是“代购药”，而是管理一条合法的就医链路
Not drug sourcing. A managed, lawful care journey.
SYSTEM A · CN → US
中国患者赴美就医与用药协调
China-to-U.S. care and medication coordination
适合肿瘤、罕见病、复杂神经系统疾病及需要海外二诊的家庭。最终医疗决定必须由持牌医生作出。
For oncology, rare disease, complex neurological cases, and patients seeking an international second opinion. Clinical decisions remain with licensed physicians.
- 01非医疗分诊Administrative triage
收集疾病类别、已有诊断、治疗阶段和目标，不判断病情。
Capture diagnosis history, treatment stage and goals without offering clinical advice.
- 02病历整理与翻译Records and translation
形成结构化摘要；影像、病理和基因检测由医院指定方式传输。
Create a structured case summary; transfer imaging, pathology and genomic files through provider-approved channels.
- 03持牌医生二诊Licensed second opinion
由美国医院或持牌医生确认是否接诊、需要补充哪些检查。
A U.S. provider determines case acceptance and required additional tests.
- 04方案与预算Plan and estimate
医院提供医疗费用估算；协调方单独列示服务费，不与药价捆绑。
The provider estimates medical costs; coordination fees are separate from medicine costs.
- 05赴美诊疗Travel for treatment
患者办理合适签证、保险和行程，到院后由美国医生开具处方。
The patient arranges suitable visa, insurance and travel; prescriptions are issued by the treating U.S. clinician.
- 06合法获得药品Lawful dispensing
药品仅由美国持牌药房或医疗机构按有效处方调配。
Medicines are dispensed only by a licensed U.S. pharmacy or healthcare facility under a valid prescription.
- 07回国前合规核验Pre-return compliance check
逐药核查中国批准状态、海关要求、合理自用数量、冷链及管制属性。
Check Chinese approval, customs, personal-use quantity, cold-chain and controlled-substance status for each product.
- 08国内延续治疗Continuity of care
将英文诊疗记录交由中国持牌医生评估，建立监测与不良反应处理计划。
A licensed Chinese clinician reviews the U.S. records and establishes monitoring and adverse-event plans.
患者个人携带回国
Patient-carried medication
不是自动合法。必须逐项确认处方、原包装、数量、申报和药品属性。
Not automatically permitted. Prescription, original packaging, quantity, declaration and product status must be checked.
中国特许医疗路径
Special-access care in China
可评估博鳌乐城等指定机构的临床急需进口药械、临床试验或其他制度化路径。
Assess designated special-access institutions, clinical trials, or other institution-led pathways.
SYSTEM B · US → CN
海外患者来华就医协调
International-patient care coordination in China
适合自费患者寻求中国医院的专科诊疗、手术、体检、康复或中西医结合服务。
For self-pay patients seeking specialist care, surgery, diagnostics, rehabilitation, or integrative care in China.
- 01需求与适配筛选Needs and fit screening
明确诊疗目标、紧急程度、预算、语言和行动能力。
Define the care goal, urgency, budget, language and mobility needs.
- 02医院国际部匹配Hospital matching
优先选择有国际医疗部、外宾流程和明确收费机制的正规医疗机构。
Prioritize accredited hospitals with international departments and transparent self-pay processes.
- 03病历预审Pre-arrival review
经患者明确授权后，将必要病历交给拟接诊机构，获得接诊意见。
With explicit consent, share necessary records with the proposed provider for acceptance review.
- 04费用与时间表Estimate and timeline
区分医院费、医生费、药品耗材、翻译、交通住宿和协调服务费。
Separate hospital, physician, medication, translation, travel and coordination costs.
- 05签证与行程核验Entry and itinerary check
计划性治疗应预留足够停留时间；不要默认使用过境免签。
Planned treatment needs adequate stay time; do not assume transit-without-visa eligibility.
- 06到院与双语陪诊Arrival and bilingual support
完成实名登记、知情同意、支付、翻译和院内流程协调。
Support registration, informed consent, payment, interpretation and hospital navigation.
- 07出院资料国际化International discharge pack
整理诊断、手术、用药、影像及随访建议的中英文件。
Prepare bilingual diagnoses, procedure notes, medication lists, imaging and follow-up instructions.
- 08回国连续照护Post-return continuity
与患者本国医生交接；药物带回美国须另行核查 FDA、CBP 和 DEA 要求。
Handoff to the home-country clinician; medicines carried to the U.S. require separate FDA, CBP and DEA review.
02
可做与不可做
Permitted and prohibited conduct
把边界写进产品，而不是出事后再解释
Compliance must be built into the product.
✓
服务可以提供
Services we can provide
- 医院与持牌医生信息整理、预约协调
- Provider research and appointment coordination
- 病历结构化、翻译与患者授权传输
- Record organization, translation and consent-based transfer
- 医院费用估算收集与自费流程说明
- Collection of provider estimates and self-pay guidance
- 签证材料清单、行程和非医疗陪同
- Visa-document checklists, itinerary and non-clinical support
- 合规路径研究并转交专业律师确认
- Compliance pathway research for counsel confirmation
×
平台绝不提供
Services we do not provide
- 无证诊断、治疗建议或修改处方
- Unlicensed diagnosis, treatment advice or prescription changes
- 购买、囤积、拆装、转售或邮寄药品
- Purchasing, stocking, repackaging, reselling or shipping medicine
- 承诺药物疗效、签证获批或海关放行
- Guarantees of outcome, visa approval or customs clearance
- 通过个人行李批量带药或规避申报
- Bulk carriage or customs-evasion arrangements
- 按处方药销售额抽佣或隐瞒利益关系
- Undisclosed medicine commissions or conflicted referrals
业务环节Activity
默认规则Default rule
上线前文件Required before launch
医疗判断Clinical decisions
仅由接诊地持牌医生完成
Licensed treating clinician only
服务边界、医生资质验证
Scope policy and license verification
药品获得Medicine access
有效处方 + 持牌药房/医院
Valid prescription + licensed dispenser
不经手药品、不收药品款条款
No custody or payment-handling clause
转诊收费Referral fees
固定协调费，避免与处方和治疗额挂钩
Fixed coordination fees, not tied to treatment value
收费表、利益冲突披露、律师审查
Fee schedule, disclosures and legal review
医疗数据Health data
最小必要、单独同意、可撤回
Minimum necessary, explicit consent, revocable
隐私政策、跨境传输同意、供应商协议
Privacy notice, transfer consent and vendor agreements
宣传材料Marketing
不使用治愈率、保结果或虚假医生背书
No cure claims, guarantees or false endorsements
医学内容审核与版本记录
Medical-content review and version log
ENTRY CHECK · 2026-06-10
美国护照来中国：
U.S. passport holders:
美国护照来中国：
不是“一律免签10天”
U.S. passport holders:
not a blanket 10-day visa exemption
符合条件的美国公民可申请240小时过境免签，但核心条件是从一个国家或地区经中国前往不同的第三国或地区，并从指定口岸入境、在允许区域活动。
Eligible U.S. citizens may apply for 240-hour visa-free transit only when traveling from one country/region through China to a different third country/region, using eligible ports and permitted areas.
✓
USA → China → Japan / Hong Kong
×USA → China → USA
计划手术、疗程较长或行程不满足第三地条件时，应提前向中国使领馆或签证中心确认适用签证。入境决定由边检机关作出。
For planned surgery, longer treatment, or non-qualifying itineraries, confirm the appropriate visa with a Chinese consulate or visa center. Admission remains at border authorities’ discretion.
240小时过境免签快速判断
240-hour transit eligibility screen
i
这是初步筛选，不构成入境许可。
This is a preliminary screen, not entry authorization.
03
可持续商业模式
Sustainable business model
靠专业协调收费，不靠药品差价
Earn from coordination, never medicine markup.
初步路径评估
Pathway assessment
病例资料清单、国家和机构路径、风险点与下一步。
Document checklist, pathway options, risks and next actions.
固定咨询费Fixed advisory fee二诊协调包
Second-opinion package
病历整理、翻译、医院沟通、预约与费用估算收集。
Records, translation, provider outreach, booking and estimates.
按项目收费Project fee全程医疗旅行协调
End-to-end care journey
签证材料、行程、陪诊、结算协调、出院资料和回国交接。
Entry documents, travel, navigation, billing, discharge and handoff.
基础费 + 服务范围Base fee + scoped services机构合作服务
Institutional services
为医院提供国际患者线索筛选、双语材料和非医疗客户服务。
Qualified intake, bilingual materials and non-clinical patient support for providers.
月度服务费Monthly service fee
04
专题指南
Patient guides
把复杂问题拆成可以分享、可以搜索、可以转化的内页
Focused pages for search, sharing, and qualified inquiries.
海外二诊资料清单
International second-opinion checklist
适合正在考虑美国医生意见、海外治疗或临床试验的家庭。
For families considering U.S. specialist review, treatment, or clinical-trial screening.
查看内页Open guide →合法用药路径评估
Medication pathway review
解释为什么不能做药品代购，以及合规路径如何逐项核验。
Why informal medicine sourcing is unsafe, and how lawful pathways are reviewed.
查看内页Open guide →国际患者来华就医
China care for international patients
面向海外华人和国际患者，说明中国自费医疗、双语陪诊和回国交接。
For self-pay patients considering China-based care, bilingual support, and continuity planning.
查看内页Open guide →
04
本地隐私模式
Private local intake
先生成一份需求简报
Generate a care-request brief
此演示版不会上传或发送你填写的内容。请勿填写姓名、身份证号、病历号或上传医疗文件。点击生成后，信息只在当前浏览器中整理。
This demo does not upload or transmit your entries. Do not enter names, IDs, medical record numbers, or upload medical files. Your brief is generated only in this browser.
●不上传 · 不存储 · 可下载No upload · No storage · Downloadable
CARE BRIEF
需求简报已生成
Care brief generated
05
FAQ
开始之前，先确认这些问题
Questions to resolve before you begin
能不能直接从美国药房寄药到中国？Can a U.S. pharmacy simply ship medicine to China?
不能作为默认方案。药品是否在中国获批、是否为处方药或管制品、进口主体、数量、运输条件和海关申报都会影响合法性。平台只帮助识别制度化路径并交由持牌机构及律师确认。
Not as a default pathway. Approval status, prescription and controlled-drug rules, importer status, quantity, transport conditions, and customs declarations all matter.
“少量自用可能减免处罚”是不是等于合法？Does possible penalty mitigation make personal import lawful?
不是。处罚裁量不等于事前许可，也不能支撑商业化代购、批量携带或转售。
No. Enforcement discretion is not pre-authorization and cannot support commercial sourcing, bulk carriage, or resale.
美国人来中国看病可以直接免签吗？Can Americans enter China visa-free for treatment?
不能一概而论。240小时政策是过境免签，需要真实前往第三国或地区；美国—中国—美国通常不满足。计划治疗应向中国使领馆或签证中心核实。
Not categorically. The 240-hour policy is for genuine onward transit to a third country/region; U.S.–China–U.S. usually does not qualify.
为什么网页现在不让上传病历？Why is medical-record upload disabled?
医疗健康信息属于敏感个人信息。正式上线前需要完成隐私政策、单独同意、跨境数据机制、加密存储、访问控制和供应商协议，不能先收集再补合规。
Health data is sensitive. A production upload flow requires consent, cross-border transfer controls, encryption, access controls, retention rules, and vendor agreements.
规则依据与更新
Sources and updates
政策会变化，每个病例都需要重新核验
Rules change. Every case requires a fresh check.
U.S. FDA · Personal Importation ↗
China NIA · Entry & Transit Policies ↗
China NMPA · Drug Regulation ↗
State Council · Boao Lecheng Policy ↗
网页规则核验日期：2026年6月10日。正式签约和接收敏感信息前，须由中国药品与数据律师、美国医疗与州法律师分别审查。
Policy review date: June 10, 2026. Before contracting or collecting sensitive data, obtain separate review from qualified Chinese drug/data counsel and U.S. healthcare/state counsel.